Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Fillit

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The American Journal of Geriatric Pharmacotherapy|December 13, 2006
Recommendations for best practices in the treatment of Alzheimer's disease in managed careHoward M Fillit, Rachelle Smith Doody, Kimberly Binaso, et al.
Annals of the New York Academy of Sciences|April 16, 2010
Therapeutics for cognitive agingDiana W Shineman, Timothy A Salthouse, Lenore J Launer, et al.
Brain Communications|April 14, 2026
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's diseaseLauren N Koenig, Hanna Huber, Anjalika Chongtham, et al.
Nature Reviews. Drug Discovery|July 2, 2013
Optimizing the use of CROs by academia and small companiesRachel F Lane, Lauren G Friedman, Curtis Keith, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 11, 2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patientsDawn C Matthews, Jefferson W Kinney, Aaron Ritter, et al.
Mayo Clinic Proceedings|July 11, 2002
Achieving and maintaining cognitive vitality with agingHoward M Fillit, Robert N Butler, Alan W O'Connell, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Overcoming obstacles to repurposing for neurodegenerative diseaseDiana W Shineman, John Alam, Margaret Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S Research & Therapy|September 28, 2011
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studiesDiana W Shineman, Guriqbal S Basi, Jennifer L Bizon, et al.
The Journal of Prevention of Alzheimer'S Disease|July 7, 2015
Dementia Prevention: optimizing the use of observational data for personal, clinical, and public health decision-makingPenny A Dacks, Sandrine Andrieu, Deborah Blacker, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Geriatric Pharmacotherapy|December 13, 2006
Recommendations for best practices in the treatment of Alzheimer's disease in managed careHoward M Fillit, Rachelle Smith Doody, Kimberly Binaso, et al.
Annals of the New York Academy of Sciences|April 16, 2010
Therapeutics for cognitive agingDiana W Shineman, Timothy A Salthouse, Lenore J Launer, et al.
Brain Communications|April 14, 2026
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's diseaseLauren N Koenig, Hanna Huber, Anjalika Chongtham, et al.
Nature Reviews. Drug Discovery|July 2, 2013
Optimizing the use of CROs by academia and small companiesRachel F Lane, Lauren G Friedman, Curtis Keith, et al.
Alzheimer'S & Dementia (New York, N. Y.)|July 11, 2024
Relationships between plasma biomarkers, tau PET, FDG PET, and volumetric MRI in mild to moderate Alzheimer's disease patientsDawn C Matthews, Jefferson W Kinney, Aaron Ritter, et al.
Mayo Clinic Proceedings|July 11, 2002
Achieving and maintaining cognitive vitality with agingHoward M Fillit, Robert N Butler, Alan W O'Connell, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
Overcoming obstacles to repurposing for neurodegenerative diseaseDiana W Shineman, John Alam, Margaret Anderson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Alzheimer'S Research & Therapy|September 28, 2011
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studiesDiana W Shineman, Guriqbal S Basi, Jennifer L Bizon, et al.
The Journal of Prevention of Alzheimer'S Disease|July 7, 2015
Dementia Prevention: optimizing the use of observational data for personal, clinical, and public health decision-makingPenny A Dacks, Sandrine Andrieu, Deborah Blacker, et al.
Pageof 6